about
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of no...
Read More
7.15
-0.20
(-2.72%)
59,782
XNAS Volume
XNAS 11 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
FibroGen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..